Abstract
Ferritin catalyzes the oxidation of Fe2+ by O2 to form a reconstituted Fe3+ oxy-hydroxide mineral core, but extensive studies have shown that the Fe2+ to O2 stoichiometry changes with experimental conditions. At Fe2+ to horse spleen ferritin (HoSF) ratios greater than 200, an upper limit of Fe2+ to O2 of 4 is typically measured, indicating O2 is reduced to 2H2O. In contrast, a lower limit of Fe2+ to O2 of approximately 2 is measured at low Fe2+ to HoSF ratios, implicating H2O2 as a product of Fe2+ deposition. Stoichiometric amounts of H2O2 have not been measured, and H2O2 is proposed to react with an unknown system component. Evidence is presented that identifies this component as amine buffers, including 3-N-morpholinopropanesulfonic acid (MOPS), which is widely used in ferritin studies. In the presence of non-amine buffers, the Fe2+ to O2 stoichiometry was approximately 4.0, but at high concentrations of amine buffers (0.10 M) the Fe2+ to O2 stoichiometry is approximately 2.5 for iron loadings of eight to 30 Fe2+ per HoSF. Decreasing the concentration of amine buffer to zero resulted in an Fe2+ to O2 stoichiometry of approximately 4. Direct evidence for amine buffer modification during Fe2+ deposition was obtained by comparing authentic and modified buffers using mass spectrometry, NMR, and thin layer chromatography. Tris(hydroxymethyl)aminomethane, MOPS, and N-methylmorpholine (a MOPS analog) were all rapidly chemically modified during Fe2+ deposition to form N-oxides. Under identical conditions no modification was detected when amine buffer, H2O2, and O2 were combined with Fe2+ or ferritin separately. Thus, a short-lived ferritin intermediate is required for buffer modification by H2O2. Variation of the Fe2+ to O2 stoichiometry versus the Fe2+ to HoSF ratio and the amine buffer concentration are consistent with buffer modification.
Similar content being viewed by others
Notes
During the iron deposition process, Escherichia coli bacterioferritin initially generates H2O2 at the FC, which then reacts rapidly with Fe2+ to form water [28], whereas Azotobacter vinelandii bacterioferritin generates water directly [29]. In both cases, an Fe2+ to O2 stoichiometry of 4 is observed.
Two forms of unmodified MOPS were observed by 1H NMR: (1) One from solid MOPS immediately dissolved in D2O (seven peaks were shown, cf. Fig. 2a in [41]) and (2) MOPS aqueous solution evaporated to dryness and dissolved in D2O (Fig. 5b). The differences between these two spectra are due to the protons on C4 and C5. In dissolved MOPS solid, the protons attached to C4 or C5 are nonexchangeable or diastereotopic, because of different orientations, i.e., axial and equatorial, when the morpholine ring exhibits a chair structure; however, for the evaporated and redissolved MOPS sample the protons on C4 or C5 are identical and only five peaks were observed. Since all the MOPS oxidation samples were prepared by evaporation and redissolving, the NMR spectrum of the second form of MOPS is shown for direct comparison.
Abbreviations
- COSY:
-
Correlation spectroscopy
- FC:
-
Ferroxidase center
- HEPES:
-
N-2-Hydroxyethylpiperazine-N-2-ethanesulfonic acid
- HoSF:
-
Horse spleen ferritin
- MOPS:
-
3-N-Morpholinopropanesulfonic acid
- NMM:
-
N-Methylmorpholine
- NMO:
-
N-Methylmorpholine N-oxide
- rHF:
-
Recombinant human heavy ferritin
- rLF:
-
Recombinant human light ferritin
- TES:
-
N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid
- TLC:
-
Thin layer chromatography
- Tris:
-
Tris(hydroxymethyl)aminomethane
References
Proulx-Curry PM, Chasteen ND (1995) Coord Chem Rev 144:347–368
Harrison PM, Arosio P (1996) Biochim Biophys Acta 1275:161–203
Waldo GS, Theil EC (1996) Ferritin and iron biomineralization. Pergamon, Oxford
Chasteen ND, Harrison PM (1999) J Struct Biol 126:182–194
Theil EC (1987) Annu Rev Biochem 56:289–316
Xu B, Chasteen ND (1991) J Biol Chem 266:19965–19970
Sun S, Arosio P, Levi S, Chasteen ND (1993) Biochemistry 32:9362–9369
Waldo GS, Theil EC (1993) Biochemistry 32:13262–13269
Yang X, Chen-Barrett Y, Arosio P, Chasteen ND (1998) Biochemistry 37:9743–9750
Sun S, Chasteen ND (1992) J Biol Chem 267:25160–25166
Macara IG, Hoy TG, Harrison PM (1972) Biochem J 126:151–162
Crichton RR, Roman F (1978) J Mol Catal 4:75–82
Bou-Abdallah F, Papaefthymiou GC, Scheswohl DM, Stanga SD, Arosio P, Chasteen ND (2002) Biochem J 364:57–63
Bauminger ER, Harrison PM, Hechel D, Hodson NW, Nowik I, Treffry A, Yewdall SJ (1993) Biochem J 296:709–719
Treffry A, Zhao Z, Quail MA, Guest JR, Harrison PM (1995) Biochemistry 34:15204–15213
Hwang J, Krebs C, Huynh BH, Edmondson DE, Theil EC, Penner-Hahn JE (2000) Science 287:122–125
Pereira A, Small W, Krebs C, Tavares P, Edmondson D, Theil E, Huynh B (1998) Biochemistry 37:9871–9876
Moenne-Loccoz P, Krebs C, Herlihy K, Edmondson D, Theil E, Huynh B, Loehr T (1999) Biochemistry 38:5290–5295
Jameson GN, Jin W, Krebs C, Perreira AS, Tavares P, Liu X, Theil EC, Huynh BH (2002) Biochemistry 41:13435–13443
Bou-Abdallah F, Zhao G, Mayne HR, Arosio P, Chasteen ND (2005) J Am Chem Soc 127:3885–3893
Yang X, Chicanoe E, Stefanini S, Ilari A, Chasteen ND (2000) Biochem J 349:783–786
Yang X, Chasteen ND (1999) Biochem J 338:615–618
Treffry A, Sowerby JM, Harrison PM (1978) FEBS Lett 95:221–224
Treffry A, Zhao Z, Quail MA, Guest JR, Harrison PM (1998) FEBS Lett 432:213–218
Zhao G, Bou-Abdallah F, Arosio P, Levi S, Janus-Chandler C, Chasteen ND (2003) Biochemistry 42:3142–3150
Bunker J, Lowry T, Davis G, Zhang B, Brosnahan D, Lindsay S, Costen R, Watt GD (2005) Biophys Chem 114:235–244
Lowery TJ, Bunker J, Zhang B, Costen R, Watt GD (2004) Biophys Chem 111:173–181
Yang X, Le Brun NE, Thomson AJ, Moore GR, Chasteen ND (2000) Biochemistry 39:4915–4923
Watt GD, Frankel RB, Jacobs D, Heqing H, Papaefthymiou GC (1992) Biochemistry 31:5672–5679
Zhao G, Bou-Abdallah F, Yang X, Arosio P, Chasteen ND (2001) Biochemistry 40:10832–10838
Lindsay S, Brosnahan D, Watt GD (2001) Biochemistry 40:3340–3347
Bergstad K, Backvall JE (1998) J Org Chem 63:6650–6655
Rosenau T, Potthast A, Kosma P (1999) Synlett 1972–1974
Zhao G, Chasteen ND (2006) Anal Biochem 349:262–267
Treffry A, Harrison PM (1979) Biochem J 181:709–716
Watt GD, Frankel RB (1991) In: Frankel RB, Blakemore RP (eds) Iron biominerals. Plenum, New York, pp 307–313
Watt RK, Frankel RB, Watt GD (1992) Biochemistry 31:9673–9679
Lindsay S, Brosnahan D, Lowery TJ Jr, Crawford K, Watt GD (2003) Biochim Biophys Acta 1621:57–66
Polanams J, Ray AD, Watt RK (2005) Inorg Chem 44:3203–3209
Cheng YG, Chasteen ND (1991) Biochemistry 30:2947–2953
Gard JK, Hutton WC, Baker JA, Singh RK, Feng PC (1999) Pestic Sci 55:215–217
Beauvais LG, Lippard SJ (2005) J Am Chem Soc 127:7370–7378
Mayer DE, Rohrer JS, Schoeller DA, Harris DC (1983) Biochemistry 22:876–880
Hodges GR, Ingold KU (2000) Free Radical Res 33:547–550
Chen-Barrett Y, Harrison PM, Treffry A, Quail MA, Arosio P, Santambrogio P, Chasteen ND (1995) Biochemistry 34:7847–7853
Van Dyke BR, Clopton DA, Saltman P (1996) Inorg Chim Acta 242:57–61
Murphy PA, Lin JS, Olcott HS (1974) Arch Biochem Biophys 164:776–777
Halliwell B, Gutteridge JMC (1986) Arch Biochem Biophys 246:501–514
Van Eden ME, Aust SD (2001) Free Radical Biol Med 31:1007–1017
Acknowledgements
We thank Li Du for help with NMR spectroscopy and Tom Lowery for helpful discussion. This research was supported by NASA grant NCC-1-02005 and the Department of Chemistry and Biochemistry of Brigham Young University.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Zhang, B., Wilson, P.E. & Watt, G.D. Ferritin-catalyzed consumption of hydrogen peroxide by amine buffers causes the variable Fe2+ to O2 stoichiometry of iron deposition in horse spleen ferritin. J Biol Inorg Chem 11, 1075–1086 (2006). https://doi.org/10.1007/s00775-006-0141-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-006-0141-6